Mohammad Asim

Years Active: 2017-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Radu Costin Bizga Nicolescu, Zoe R Maylin, Francisco Javier Pérez-Areales, Jessica Iegre, Hardev S Pandha, Mohammad Asim, David R Spring
Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI-001 in in vitro Models of Prostate Cancer Drug Resistance. ChemMedChem (2022)
Mohammad Asim, Firas Tarish, Heather I Zecchini, Kumar Sanjiv, Eleni Gelali, Charles E Massie, Ajoeb Baridi, Anne Y Warren, Wanfeng Zhao, Christoph Ogris, Leigh-Anne McDuffus, Patrice Mascalchi, Greg Shaw, Harveer Dev, Karan Wadhwa, Paul Wijnhoven, Josep V Forment, Scott R Lyons, Andy G Lynch, Cormac O'Neill, Vincent R Zecchini, Paul S Rennie, Aria Baniahmad, Simon Tavaré, Ian G Mills, Yaron Galanty, Nicola Crosetto, Niklas Schultz, David E Neal, Thomas Helleday
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer. Nature communications 8 (1) (2017)

Mohammad Asim.css-eqlu8i{font-size:small;padding-left:4px;}